Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 2
1985 1
1986 1
1987 2
1988 2
1989 2
1990 3
1991 2
1992 3
1993 2
1994 6
1995 6
1996 5
1997 5
1998 10
1999 12
2000 10
2001 8
2002 1
2003 1
2004 2
2005 4
2006 9
2007 3
2008 5
2009 6
2010 20
2011 19
2012 9
2013 6
2014 3
2015 3
2016 7
2017 6
2018 17
2019 13
2020 13
2021 13
2022 8
2023 12
2024 9

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

248 results

Results by year

Filters applied: . Clear all
Page 1
Dupilumab for COPD with Type 2 Inflammation Indicated by Eosinophil Counts.
Bhatt SP, Rabe KF, Hanania NA, Vogelmeier CF, Cole J, Bafadhel M, Christenson SA, Papi A, Singh D, Laws E, Mannent LP, Patel N, Staudinger HW, Yancopoulos GD, Mortensen ER, Akinlade B, Maloney J, Lu X, Bauer D, Bansal A, Robinson LB, Abdulai RM; BOREAS Investigators. Bhatt SP, et al. N Engl J Med. 2023 Jul 20;389(3):205-214. doi: 10.1056/NEJMoa2303951. Epub 2023 May 21. N Engl J Med. 2023. PMID: 37272521 Clinical Trial.
Artificial intelligence-based analysis of the spatial distribution of abnormal computed tomography patterns in SARS-CoV-2 pneumonia: association with disease severity.
Kataoka Y, Tanabe N, Shirata M, Hamao N, Oi I, Maetani T, Shiraishi Y, Hashimoto K, Yamazoe M, Shima H, Ajimizu H, Oguma T, Emura M, Endo K, Hasegawa Y, Mio T, Shiota T, Yasui H, Nakaji H, Tsuchiya M, Tomii K, Hirai T, Ito I. Kataoka Y, et al. Among authors: mio t. Respir Res. 2024 Jan 10;25(1):24. doi: 10.1186/s12931-024-02673-w. Respir Res. 2024. PMID: 38200566 Free PMC article.
Treatment patterns and clinical outcomes of resectable clinical stage III non-small cell lung cancer in a Japanese real-world setting: Surgery cohort analysis of the SOLUTION study.
Tsuboi M, Murakami H, Harada H, Sobue T, Kato T, Atagi S, Tokito T, Mio T, Adachi H, Kozuki T, Sone T, Seike M, Toyooka S, Kitagawa H, Koto R, Yamazaki S, Horinouchi H. Tsuboi M, et al. Among authors: mio t. Thorac Cancer. 2024 Jul;15(20):1541-1552. doi: 10.1111/1759-7714.15305. Epub 2024 May 29. Thorac Cancer. 2024. PMID: 38812106 Free PMC article.
Natural course of pulmonary hyalinizing granuloma over a decade.
Fujita K, Okamura M, Imakita T, Yamamoto Y, Sawai S, Moriyoshi K, Mio T. Fujita K, et al. Among authors: mio t. Respir Med Case Rep. 2022 Jul 31;39:101715. doi: 10.1016/j.rmcr.2022.101715. eCollection 2022. Respir Med Case Rep. 2022. PMID: 35958350 Free PMC article.
Selective TRK Inhibitor CH7057288 against TRK Fusion-Driven Cancer.
Tanaka H, Sase H, Tsukaguchi T, Hasegawa M, Tanimura H, Yoshida M, Sakata K, Fujii T, Tachibana Y, Takanashi K, Higashida A, Hasegawa K, Ono Y, Oikawa N, Mio T. Tanaka H, et al. Among authors: mio t. Mol Cancer Ther. 2018 Dec;17(12):2519-2529. doi: 10.1158/1535-7163.MCT-17-1180. Epub 2018 Sep 21. Mol Cancer Ther. 2018. PMID: 30242093
High sensitivity C-reactive protein in asthma.
Takemura M, Matsumoto H, Niimi A, Ueda T, Matsuoka H, Yamaguchi M, Jinnai M, Muro S, Hirai T, Ito Y, Nakamura T, Mio T, Chin K, Mishima M. Takemura M, et al. Among authors: mio t. Eur Respir J. 2006 May;27(5):908-12. doi: 10.1183/09031936.06.00114405. Eur Respir J. 2006. PMID: 16707391 Free article.
248 results